Demant A/S (CPH:DEMANT)
278.40
+0.60 (0.22%)
Jul 20, 2026, 4:59 PM CET
Demant Revenue
In the year 2025, Demant had annual revenue of 22.97B DKK with 2.46% growth. Demant had revenue of 11.72B in the half year ending December 31, 2025, with 3.81% growth.
Revenue
22.97B
Revenue Growth
+2.46%
P/S Ratio
2.55
Revenue / Employee
916.02K
Employees
26,704
Market Cap
58.59B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.97B | 552.00M | 2.46% |
| Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
| Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
| Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
| Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
| Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
| Dec 31, 2019 | 14.95B | 1.01B | 7.24% |
| Dec 31, 2018 | 13.94B | 748.00M | 5.67% |
| Dec 31, 2017 | 13.19B | 1.19B | 9.89% |
| Dec 31, 2016 | 12.00B | 1.34B | 12.54% |
| Dec 31, 2015 | 10.67B | 1.32B | 14.11% |
| Dec 31, 2014 | 9.35B | 387.00M | 4.32% |
| Dec 31, 2013 | 8.96B | 404.00M | 4.72% |
| Dec 31, 2012 | 8.56B | 514.00M | 6.39% |
| Dec 31, 2011 | 8.04B | 1.15B | 16.67% |
| Dec 31, 2010 | 6.89B | 1.19B | 20.89% |
| Dec 31, 2009 | 5.70B | 327.50M | 6.09% |
| Dec 31, 2008 | 5.37B | -114.60M | -2.09% |
| Dec 31, 2007 | 5.49B | 403.24M | 7.93% |
| Dec 31, 2006 | 5.09B | 562.13M | 12.43% |
| Dec 31, 2005 | 4.52B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
Demant News
- 3 days ago - Demant downgraded to Market Perform from Outperform at Bernstein - TheFly
- 14 days ago - Demant price target raised to DKK 258 from DKK 226 at Deutsche Bank - TheFly
- 27 days ago - Demant upgraded to Overweight from Equal Weight at Morgan Stanley - TheFly
- 5 weeks ago - Demant upgraded to Buy from Underperform at BofA - TheFly
- 2 months ago - Demant price target raised to DKK 226 from DKK 211 at Deutsche Bank - TheFly
- 2 months ago - Demant Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Demant Earnings release: Q1 2026 - Filings
- 3 months ago - Demant price target raised to DKK 210 from DKK 207 at Morgan Stanley - TheFly